NASDAQ Global Market • Healthcare • Biotechnology • IL • USD
Gamida Cell Ltd. (GMDA) has a consensus analyst rating of Buy, based on 8 analysts covering the stock. Of those, 7 recommend buying, 1 recommend holding, and 0 recommend selling.
No price target data available.
Be the first to know when stocks drop below their intrinsic value.
